TET2 and acute myeloid leukemia: Building on these findings, TET2-mediated m5C oxidation of caRNA was examined in AML models, where TET2 deficiency led to elevated caRNA m5C levels, increased global transcription, and enhanced chromatin accessibility, consistent with a role in disease progression [67].